Tsai Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,788
Closed -$370K 21
2025
Q4
$370K Sell
1,788
-672
-27% -$133K 0.25% 19
2025
Q3
$456K Hold
2,460
0.32% 21
2025
Q2
$376K Hold
2,460
0.28% 27
2025
Q1
$408K Hold
2,460
0.34% 25
2024
Q4
$356K Hold
2,460
0.26% 25
2024
Q3
$399K Hold
2,460
0.32% 25
2024
Q2
$360K Hold
2,460
0.35% 24
2024
Q1
$389K Hold
2,460
0.4% 23
2023
Q4
$386K Hold
2,460
0.35% 23
2023
Q3
$383K Hold
2,460
0.37% 22
2023
Q2
$407K Hold
2,460
0.37% 22
2023
Q1
$381K Hold
2,460
0.4% 21
2022
Q4
$435K Hold
2,460
0.63% 20
2022
Q3
$402K Hold
2,460
0.45% 20
2022
Q2
$437K Hold
2,460
0.52% 18
2022
Q1
$436K Hold
2,460
0.33% 14
2021
Q4
$421K Hold
2,460
0.29% 15
2021
Q3
$397K Hold
2,460
0.34% 16
2021
Q2
$405K Sell
2,460
-800
-25% -$132K 0.37% 17
2021
Q1
$536K Hold
3,260
0.53% 16
2020
Q4
$513K Buy
+3,260
New +$481K 0.51% 14

Other funds holding JNJ

Tsai Capital's JNJ Position: Q1 2026 in Review

Tsai Capital sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 1,788 shares — an estimated $370K sold.

Tsai Capital first reported a position in JNJ in Q4 2020 and held it in 21 quarters. The position peaked at $536K in Q1 2021. 4,641 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Tsai Capital reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Tsai Capital sold 1,788 Johnson & Johnson shares in Q1 2026, an estimated $370K.
  • Tsai Capital first reported a position in Johnson & Johnson in Q4 2020 and held it in 21 quarters.
  • Tsai Capital's Johnson & Johnson position peaked at $536K in Q1 2021.
  • 4,641 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Tsai Capital's 13F filing for Q1 2026, filed 14 May 2026.